These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6407348)

  • 21. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide.
    Pottage A
    Am J Cardiol; 1983 Sep; 52(6):24C-31C. PubMed ID: 6414279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
    Camm AJ
    Eur Heart J; 1984 Sep; 5 Suppl B():75-9. PubMed ID: 6437820
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
    Podrid PJ
    Chest; 1985 Oct; 88(4):618-24. PubMed ID: 3930162
    [No Abstract]   [Full Text] [Related]  

  • 24. Electropharmacology of antiarrhythmic drugs.
    Rosen MR; Wit AL
    Am Heart J; 1983 Oct; 106(4 Pt 2):829-39. PubMed ID: 6412533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newer antiarrhythmic drugs.
    Hess D
    West J Med; 1981 Apr; 134(4):333-41. PubMed ID: 6787808
    [No Abstract]   [Full Text] [Related]  

  • 26. Tocainide and metoprolol: an efficacious therapeutic combination in the treatment of premature ventricular beats.
    Capucci A; Frabetti L; Gubelli S; Boriani G; Marchesini B; Boschi S; Ambrosioni E; Magnani B
    Clin Cardiol; 1989 Jun; 12(6):322-31. PubMed ID: 2472242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy of antiarrhythmic agents in preventing halothane-epinephrine arrhythmias in rats.
    Takada K; Sumikawa K; Kamibayashi T; Hayashi Y; Yamatodani A; Kawabata K; Yoshiya I
    Anesthesiology; 1993 Sep; 79(3):563-70. PubMed ID: 8363083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second generation antiarrhythmic agents: have we reached antiarrhythmic Nirvana?
    Horowitz LN; Morganroth J
    J Am Coll Cardiol; 1987 Feb; 9(2):459-63. PubMed ID: 3100601
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
    Singh BN; Cho YW; Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):185-99. PubMed ID: 6788721
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of unstable angina with emphasis on calcium antagonists.
    Hugenholtz PG; Michels R; Serruys PW; Simoons ML
    G Ital Cardiol; 1984 Nov; 14(11):917-26. PubMed ID: 6441734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
    Ross DL; Sze DY; Keefe DL; Swerdlow CD; Echt DS; Griffin JC; Winkle RA; Mason JW
    Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic drug therapy. Recent advances and current status.
    Somberg J
    Cardiology; 1985; 72(5-6):329-48. PubMed ID: 2866841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine.
    Snyder DW
    J La State Med Soc; 1989 May; 141(5):21-5. PubMed ID: 2499645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical pharmacology of lidocaine congeners--review of encainide, flecainide, lorcainide and tocainide.
    McDevitt DG
    Eur Heart J; 1984 Sep; 5 Suppl B():63-6. PubMed ID: 6437818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of anti-arrhythmia drugs on mouse arrhythmia induced by Bufonis Venenum].
    Lu WJ; Zhou J; Ma HY; Lü GH; You FQ; Ding AW; Duan JA
    Yao Xue Xue Bao; 2011 Oct; 46(10):1187-92. PubMed ID: 22242448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-arrhythmic effect of nadolol in experimental arrhythmias: comparison with propranolol and alprenolol.
    Nakashima M; Takiguchi Y; Oguro K; Sogabe K; Hashimoto H
    J Pharmacobiodyn; 1985 Jan; 8(1):1-10. PubMed ID: 4009395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacology of old and new antiarrhythmic drugs.
    Siddoway LA; Roden DM; Woosley RL
    Cardiovasc Clin; 1985; 15(3):199-248. PubMed ID: 2870805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology of antiarrhythmic agents.
    Kelliher GJ; Kowey P; Engel T; Wetstein L
    Cardiovasc Clin; 1985; 16(1):287-305. PubMed ID: 2874883
    [No Abstract]   [Full Text] [Related]  

  • 39. Combination of antiarrhythmic drugs.
    Lüderitz B; Mletzko R; Jung W; Manz M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S48-52. PubMed ID: 1723119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic effects of concurrent administration of metoprolol and tocainide in acute myocardial infarction.
    Renard MB; Bernard RM; Ewalenko MB; Englert M
    J Cardiovasc Pharmacol; 1983; 5(1):116-20. PubMed ID: 6186845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.